CN1772239A - 一种治疗阴道炎宫颈炎的中药制剂 - Google Patents
一种治疗阴道炎宫颈炎的中药制剂 Download PDFInfo
- Publication number
- CN1772239A CN1772239A CN 200510118244 CN200510118244A CN1772239A CN 1772239 A CN1772239 A CN 1772239A CN 200510118244 CN200510118244 CN 200510118244 CN 200510118244 A CN200510118244 A CN 200510118244A CN 1772239 A CN1772239 A CN 1772239A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- alumen
- borax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 206010046914 Vaginal infection Diseases 0.000 title claims abstract description 16
- 201000008100 Vaginitis Diseases 0.000 title claims abstract description 16
- 208000006374 Uterine Cervicitis Diseases 0.000 title claims abstract description 15
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 41
- 229910021538 borax Inorganic materials 0.000 claims description 39
- 239000004328 sodium tetraborate Substances 0.000 claims description 39
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 39
- 229940079593 drug Drugs 0.000 claims description 29
- 208000003251 Pruritus Diseases 0.000 abstract description 20
- 230000002147 killing effect Effects 0.000 abstract description 13
- 239000002775 capsule Substances 0.000 abstract description 12
- 244000045947 parasite Species 0.000 abstract description 12
- 230000007803 itching Effects 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 239000000499 gel Substances 0.000 abstract description 6
- 239000000829 suppository Substances 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 abstract description 2
- 208000002894 beriberi Diseases 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 239000006210 lotion Substances 0.000 abstract description 2
- 241000212948 Cnidium Species 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 52
- 238000001035 drying Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 238000003756 stirring Methods 0.000 description 17
- 238000002156 mixing Methods 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 210000001215 vagina Anatomy 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000007938 effervescent tablet Substances 0.000 description 7
- 210000004877 mucosa Anatomy 0.000 description 7
- 238000012856 packing Methods 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- -1 Herba Agrimoniae Chemical compound 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920003081 Povidone K 30 Polymers 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000005325 percolation Methods 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 229960002233 benzalkonium bromide Drugs 0.000 description 3
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000002657 hormone replacement therapy Methods 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229960003943 hypromellose Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical class ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical class ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical group CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical class C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101182440A CN100333779C (zh) | 2005-08-10 | 2005-10-21 | 一种治疗阴道炎宫颈炎的中药制剂 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510060402 | 2005-08-10 | ||
CN200510060402.1 | 2005-08-10 | ||
CNB2005101182440A CN100333779C (zh) | 2005-08-10 | 2005-10-21 | 一种治疗阴道炎宫颈炎的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772239A true CN1772239A (zh) | 2006-05-17 |
CN100333779C CN100333779C (zh) | 2007-08-29 |
Family
ID=36759491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101182440A Active CN100333779C (zh) | 2005-08-10 | 2005-10-21 | 一种治疗阴道炎宫颈炎的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100333779C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743693A (zh) * | 2012-06-17 | 2012-10-24 | 邢霞 | 一种治疗腰骶坠胀型慢性子宫颈炎的中药冲洗剂制备方法 |
CN104606226A (zh) * | 2015-02-27 | 2015-05-13 | 赵树生 | 抗菌消炎中药栓剂及其制备方法和质控方法 |
CN106729248A (zh) * | 2017-02-20 | 2017-05-31 | 佛山市弘泰药物研发有限公司 | 一种治疗阴部瘙痒的中药组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1161199A (zh) * | 1996-04-03 | 1997-10-08 | 山西省派尔保健日化厂 | 苦参洗浴液 |
CN1071125C (zh) * | 1998-10-12 | 2001-09-19 | 范永昌 | 一种预防和治疗外阴疾病的浴洗药 |
-
2005
- 2005-10-21 CN CNB2005101182440A patent/CN100333779C/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743693A (zh) * | 2012-06-17 | 2012-10-24 | 邢霞 | 一种治疗腰骶坠胀型慢性子宫颈炎的中药冲洗剂制备方法 |
CN102743693B (zh) * | 2012-06-17 | 2013-08-21 | 黄艳 | 一种治疗腰骶坠胀型慢性子宫颈炎的中药冲洗剂制备方法 |
CN104606226A (zh) * | 2015-02-27 | 2015-05-13 | 赵树生 | 抗菌消炎中药栓剂及其制备方法和质控方法 |
CN104606226B (zh) * | 2015-02-27 | 2017-12-05 | 赵树生 | 抗菌消炎中药栓剂及其制备方法和质控方法 |
CN106729248A (zh) * | 2017-02-20 | 2017-05-31 | 佛山市弘泰药物研发有限公司 | 一种治疗阴部瘙痒的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100333779C (zh) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1061854C (zh) | 治疗、预防妇科疾患的药物制剂 | |
CN1325083C (zh) | 一种用于除湿止痒的药物组合物及其制备方法和用途 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN1031174C (zh) | 一种抗菌、灭菌洗液及其制备方法和应用 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN101507776B (zh) | 一种治疗肾虚、腰膝酸软的中药制剂及其制备方法 | |
CN102988675B (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN1709302A (zh) | 治疗慢性盆腔炎的中药制剂及其制备方法 | |
CN104225319A (zh) | 一种治疗急性肾衰竭的中药制剂 | |
CN104587302A (zh) | 一种治疗急性阑尾炎的中药制剂 | |
CN100333779C (zh) | 一种治疗阴道炎宫颈炎的中药制剂 | |
CN101912567B (zh) | 治疗慢性心肌炎的中药 | |
CN1262951A (zh) | 治疗由风寒湿所致痹症的药物及其制备方法 | |
CN101167846A (zh) | 一种具有降糖作用的胶囊及其制备方法 | |
CN103381266A (zh) | 一种治疗神经性呕吐的中药 | |
CN1689591A (zh) | 一种治疗妇科疾病的中药及其制备工艺 | |
CN110624067B (zh) | 具有减肥作用的中药组合物及其药膏的制备方法 | |
CN101036701A (zh) | 中药熏洗液 | |
CN1712055A (zh) | 一种治疗泌尿系结石的中药制剂(溶石胶囊) | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN1958028A (zh) | 一种治疗前列腺增生的中药制剂 | |
CN116350731B (zh) | 一种清热除湿通痹方及其制剂和应用 | |
CN116832125B (zh) | 一种中药组合物、制备方法及其应用 | |
CN1259970C (zh) | 治疗外感风寒的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhejiang Tian Hao Pharmaceutical Co., Ltd. Assignor: Xu Xiaogang Contract record no.: 2010330002186 Denomination of invention: Chinese medicine prepn for treating vaginitis and cervicitis Granted publication date: 20070829 License type: Exclusive License Open date: 20060517 Record date: 20101129 |
|
ASS | Succession or assignment of patent right |
Owner name: XU PENG Free format text: FORMER OWNER: XU XIAOGANG Effective date: 20140814 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 324002 QUZHOU, ZHEJIANG PROVINCE TO: 310014 HANGZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140814 Address after: 310014 room 3, unit 9, Yuanda garden, Gongshu District, Zhejiang, Hangzhou 202, China Patentee after: Xu Peng Address before: 324002 Zhejiang province Quzhou Shuguang Shuanggang road Zhejiang Economic Development Zone Tianhao Pharmaceutical Co. Ltd. Patentee before: Xu Xiaogang |
|
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG TIANHAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XU PENG Effective date: 20141029 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310014 HANGZHOU, ZHEJIANG PROVINCE TO: 324002 QUZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141029 Address after: The dawn of the road 324002 in Zhejiang province Quzhou City Kecheng District Shuanggang export processing Park No. 6 Patentee after: Zhejiang Tian Hao Pharmaceutical Co., Ltd. Address before: 310014 room 3, unit 9, Yuanda garden, Gongshu District, Zhejiang, Hangzhou 202, China Patentee before: Xu Peng |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160612 Address after: 324000 No. 889 Century Avenue, Quzhou Economic Development Zone, Zhejiang, China Patentee after: ZHEJIANG KANGDE PHARMACEUTICAL CO., LTD. Address before: The dawn of the road 324002 in Zhejiang province Quzhou City Kecheng District Shuanggang export processing Park No. 6 Patentee before: Zhejiang Tian Hao Pharmaceutical Co., Ltd. |